The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma

D. Ronchetti, K. Todoerti, G. Tuana, L. Agnelli, L. Mosca, M. Lionetti, S. Fabris, P. Colapietro, M. Miozzo, M. Ferrarini, P. Tassone, A. Neri

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Small nucleolar RNAs (snoRNAs) and small Cajal body-specific RNAs (scaRNAs) are non-coding RNAs involved in the maturation of other RNA molecules and generally located in the introns of host genes. It is now emerging that altered snoscaRNAs expression may have a pathological role in cancer. This study elucidates the patterns of snoscaRNAs expression in multiple myeloma (MM) by profiling purified malignant plasma cells from 55 MMs, 8 secondary plasma cell leukemias (sPCLs) and 4 normal controls. Overall, a global snoscaRNAs downregulation was found in MMs and, even more, in sPCLs compared with normal plasma cells. Whereas SCARNA22 resulted the only snoscaRNA characterizing the translocationcyclin D4 (TC4) MM, TC2 group displayed a distinct snoscaRNA signature overexpressing members of SNORD115 and SNORD116 families located in a region finely regulated by an imprinting center at 15q11, which, however, resulted overall hypomethylated in MMs independently of the SNORD115 and SNORD116 expression levels. Finally, integrative analyses with available gene expression and genome-wide data revealed the occurrence of significant snoscaRNAshost genes co-expression and the putative influence of allelic imbalances on specific snoRNAs expression. Our data extend the current view of snoscaRNAs deregulation in cancer and add novel information to the bio-molecular complexity of plasma cell dyscrasias.

Original languageEnglish
Article numbere96
JournalBlood Cancer Journal
Volume2
Issue number11
DOIs
Publication statusPublished - Dec 14 2012

Fingerprint

Plasma Cell Leukemia
Small Nucleolar RNA
Plasma Cells
Multiple Myeloma
Allelic Imbalance
RNA
Gene Expression
Untranslated RNA
Paraproteinemias
Introns
Neoplasms
Down-Regulation
Genome
Genes

Keywords

  • multiple myeloma
  • ncRNA
  • snoRNA

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma. / Ronchetti, D.; Todoerti, K.; Tuana, G.; Agnelli, L.; Mosca, L.; Lionetti, M.; Fabris, S.; Colapietro, P.; Miozzo, M.; Ferrarini, M.; Tassone, P.; Neri, A.

In: Blood Cancer Journal, Vol. 2, No. 11, e96, 14.12.2012.

Research output: Contribution to journalArticle

@article{5e284df52f6442f68378da1a74c8e89e,
title = "The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma",
abstract = "Small nucleolar RNAs (snoRNAs) and small Cajal body-specific RNAs (scaRNAs) are non-coding RNAs involved in the maturation of other RNA molecules and generally located in the introns of host genes. It is now emerging that altered snoscaRNAs expression may have a pathological role in cancer. This study elucidates the patterns of snoscaRNAs expression in multiple myeloma (MM) by profiling purified malignant plasma cells from 55 MMs, 8 secondary plasma cell leukemias (sPCLs) and 4 normal controls. Overall, a global snoscaRNAs downregulation was found in MMs and, even more, in sPCLs compared with normal plasma cells. Whereas SCARNA22 resulted the only snoscaRNA characterizing the translocationcyclin D4 (TC4) MM, TC2 group displayed a distinct snoscaRNA signature overexpressing members of SNORD115 and SNORD116 families located in a region finely regulated by an imprinting center at 15q11, which, however, resulted overall hypomethylated in MMs independently of the SNORD115 and SNORD116 expression levels. Finally, integrative analyses with available gene expression and genome-wide data revealed the occurrence of significant snoscaRNAshost genes co-expression and the putative influence of allelic imbalances on specific snoRNAs expression. Our data extend the current view of snoscaRNAs deregulation in cancer and add novel information to the bio-molecular complexity of plasma cell dyscrasias.",
keywords = "multiple myeloma, ncRNA, snoRNA",
author = "D. Ronchetti and K. Todoerti and G. Tuana and L. Agnelli and L. Mosca and M. Lionetti and S. Fabris and P. Colapietro and M. Miozzo and M. Ferrarini and P. Tassone and A. Neri",
year = "2012",
month = "12",
day = "14",
doi = "10.1038/bcj.2012.41",
language = "English",
volume = "2",
journal = "Blood Cancer Journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma

AU - Ronchetti, D.

AU - Todoerti, K.

AU - Tuana, G.

AU - Agnelli, L.

AU - Mosca, L.

AU - Lionetti, M.

AU - Fabris, S.

AU - Colapietro, P.

AU - Miozzo, M.

AU - Ferrarini, M.

AU - Tassone, P.

AU - Neri, A.

PY - 2012/12/14

Y1 - 2012/12/14

N2 - Small nucleolar RNAs (snoRNAs) and small Cajal body-specific RNAs (scaRNAs) are non-coding RNAs involved in the maturation of other RNA molecules and generally located in the introns of host genes. It is now emerging that altered snoscaRNAs expression may have a pathological role in cancer. This study elucidates the patterns of snoscaRNAs expression in multiple myeloma (MM) by profiling purified malignant plasma cells from 55 MMs, 8 secondary plasma cell leukemias (sPCLs) and 4 normal controls. Overall, a global snoscaRNAs downregulation was found in MMs and, even more, in sPCLs compared with normal plasma cells. Whereas SCARNA22 resulted the only snoscaRNA characterizing the translocationcyclin D4 (TC4) MM, TC2 group displayed a distinct snoscaRNA signature overexpressing members of SNORD115 and SNORD116 families located in a region finely regulated by an imprinting center at 15q11, which, however, resulted overall hypomethylated in MMs independently of the SNORD115 and SNORD116 expression levels. Finally, integrative analyses with available gene expression and genome-wide data revealed the occurrence of significant snoscaRNAshost genes co-expression and the putative influence of allelic imbalances on specific snoRNAs expression. Our data extend the current view of snoscaRNAs deregulation in cancer and add novel information to the bio-molecular complexity of plasma cell dyscrasias.

AB - Small nucleolar RNAs (snoRNAs) and small Cajal body-specific RNAs (scaRNAs) are non-coding RNAs involved in the maturation of other RNA molecules and generally located in the introns of host genes. It is now emerging that altered snoscaRNAs expression may have a pathological role in cancer. This study elucidates the patterns of snoscaRNAs expression in multiple myeloma (MM) by profiling purified malignant plasma cells from 55 MMs, 8 secondary plasma cell leukemias (sPCLs) and 4 normal controls. Overall, a global snoscaRNAs downregulation was found in MMs and, even more, in sPCLs compared with normal plasma cells. Whereas SCARNA22 resulted the only snoscaRNA characterizing the translocationcyclin D4 (TC4) MM, TC2 group displayed a distinct snoscaRNA signature overexpressing members of SNORD115 and SNORD116 families located in a region finely regulated by an imprinting center at 15q11, which, however, resulted overall hypomethylated in MMs independently of the SNORD115 and SNORD116 expression levels. Finally, integrative analyses with available gene expression and genome-wide data revealed the occurrence of significant snoscaRNAshost genes co-expression and the putative influence of allelic imbalances on specific snoRNAs expression. Our data extend the current view of snoscaRNAs deregulation in cancer and add novel information to the bio-molecular complexity of plasma cell dyscrasias.

KW - multiple myeloma

KW - ncRNA

KW - snoRNA

UR - http://www.scopus.com/inward/record.url?scp=84871189185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871189185&partnerID=8YFLogxK

U2 - 10.1038/bcj.2012.41

DO - 10.1038/bcj.2012.41

M3 - Article

VL - 2

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

IS - 11

M1 - e96

ER -